Annual Revenue ($)

Apollo Endosurgery revenue was $42.05 m in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$64.31 m$60.85 m$50.71 m$42.05 m
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$15.74 m$15.79 m$14.14 m$13.21 m$14.25 m$11.26 m$10.72 m$5.64 m$12.83 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Apollo Endosurgery revenue breakdown by business segment: 55.8% from Endoscopic Suturing System, 33.2% from Intragastric Balloon, 7.3% from Surgical and 3.7% from Other

Apollo Endosurgery revenue breakdown by geographic segment: 43.2% from US and 56.8% from Non US

FY, 2019FY, 2018FY, 2017
Surgical$3.71 m$18.71 m$27.59 m
US Orbera Starter Kit Sales$862 k
Endo-bariatric, excluding US Orbera Starter Kit Sales$35.06 m
Other$1.85 m$1.03 m$794 k
Endoscopic Suturing System$28.31 m$23.38 m
Intragastric Balloon$16.84 m$17.74 m
FY, 2019FY, 2018FY, 2017
US$21.92 m$28.21 m$32.45 m
Non US$28.79 m$32.65 m$31.86 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu